Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes
ABSTRACT To examine the effect of cranberry ingestion on lipid profiles in Type 2 diabetic patients taking oral glucose-lowering drugs.
Thirty Type 2 diabetic subjects (16 males and 14 females; mean age 65 +/- 1 years) who were taking oral glucose-lowering medication regularly were enrolled in this randomized, placebo-controlled, double-blind study. Changes in lipid profiles, oxidized low-density lipoprotein (ox-LDL), glycaemic control, components of the metabolic syndrome, C-reactive protein (CRP) and urinary albumin excretion (UAE) were assessed after cranberry or placebo treatment for 12 weeks.
Low-density lipoprotein (LDL) cholesterol decreased significantly in the cranberry group (from 3.3 +/- 0.2 to 2.9 +/- 0.2 mmol/l, P = 0.005) and the decrease was significantly greater than that in the placebo group (-0.4 +/- 0.1 vs. 0.2 +/- 0.1 mmol/l, P < 0.001). Total cholesterol and total : high-density lipoprotein (HDL) cholesterol ratio also decreased significantly (P = 0.020 and 0.044, respectively) in the cranberry group and the reductions were significantly different from those in the placebo group (P < 0.001 and P = 0.032, respectively). However, ox-LDL levels did not change significantly in response to cranberry consumption. Neither fasting glucose nor glycated haemoglobin improved in either group. Changes in components of the metabolic syndrome, UAE and CRP were not significantly different between groups.
Cranberry supplements are effective in reducing atherosclerotic cholesterol profiles, including LDL cholesterol and total cholesterol levels, as well as total : HDL cholesterol ratio, and have a neutral effect on glycaemic control in Type 2 diabetic subjects taking oral glucose-lowering agents.
- SourceAvailable from: Abishek Bommannan Santhakumar
[Show abstract] [Hide abstract]
- "Cranberry supplements reduce atherosclerotic cholesterol profiles and have a neutral effect on glycaemic control in type 2 diabetic subjects taking oral glucose-lowering agents Lee et al. (2008) Wild blueberry (anthocyanins) "
ABSTRACT: Dietary sources of polyphenols, which are derivatives and/or isomers of flavones, isoflavones, flavonols, catechins and phenolic acids, possess antioxidant properties and therefore might be important in preventing oxidative‐stress‐induced platelet activation and attenuating adverse haemostatic function. Free radicals, including reactive oxygen and nitrogen species, promote oxidative stress, leading to platelet hyperactivation and the risk of thrombosis. The consumption of antioxidant/polyphenol rich foods might therefore impart anti‐thrombotic and cardiovascular protective effects via their inhibition of platelet hyperactivation or aggregation. Most commonly‐used anti‐platelet drugs such as aspirin block the cyclooxygenase (COX)‐1 pathway of platelet activation, similar to the action of antioxidants with respect to neutralising hydrogen peroxide (H2O2), with a similar effect on thromboxane production via the COX‐1 pathway. Polyphenols also target various additional platelet activation pathways (e.g. by blocking platelet‐ADP, collagen receptors); thus alleviating fibrinogen binding to platelet surface (GPIIb‐IIIa) receptors, reducing further platelet recruitment for aggregation and inhibiting platelet degranulation. As a result of the ability of polyphenols to target additional pathways of platelet activation, they may have the potential to substitute or complement currently used anti‐platelet drugs in sedentary, obese, pre‐diabetic or diabetic populations who can be resistant or sensitive to pharmacological anti‐platelet therapy.
[Show abstract] [Hide abstract]
- "The lipid-lowering effects of some other species of Vaccinium have been demonstrated in several animal studies [24–26] and clinical trials [27, 28]. In the study of Lee et al., the use of cranberry (Vaccinium macrocarpon) extract with the daily dose of 1500 mg for 12 weeks by patients with type 2 diabetes caused significant reduction in serum levels of LDL-C and total cholesterol and total cholesterol/HDL cholesterol ratio . In contrast to our results, in a study of patients with features of metabolic syndrome, daily consumption of 400 g fresh bilberries (Vaccinium myrtillus) for 8 weeks had not any significant effect on serum lipids . "
ABSTRACT: Background. Dyslipidemia produces atherosclerosis, which in turn results in coronary artery disease (CAD). Atherosclerosis is being considered as an inflammatory disease. Vaccinium arctostaphylos L. is a plant with fruits rich in anthocyanins. The aim of this study was to evaluate the effects of fruit extract of this plant on serum levels of lipids, hs-CRP, and malondialdehyde (MDA) as a marker of oxidative stress, in hyperlipidemic adult patients. Methods. In this randomized, double-blind, placebo-controlled clinical trial, 50 hyperlipidemic adult patients were randomly and equally assigned to receive either medicinal (V. arctostaphylos fruit extract) or placebo capsules twice daily for 4 weeks. Each medicinal capsule contained 45 ± 2 mg of anthocyanins. Fasting serum levels of total cholesterol, TG, LDL-C, HDL-C, hs-CRP, and MDA were obtained before and after the intervention and compared. Results. V. arctostaphylos fruit extract significantly reduced total cholesterol (P < 0.001), LDL-C (P = 0.004), TG (P < 0.001), and MDA (P = 0.013) compared to placebo but did not have any significant effect on HDL-C (P = 0.631) and hs-CRP (P = 0.190). Conclusion. Fruit extract of Vaccinium arctostaphylos has beneficial effects on serum lipid profile and oxidative stress in hyperlipidemic adult patients. Therefore, it could be considered as a supplement for treatment of dyslipidemia and prevention of atherosclerosis development.Evidence-based Complementary and Alternative Medicine 01/2014; 2014(1):217451. DOI:10.1155/2014/217451 · 1.88 Impact Factor
[Show abstract] [Hide abstract]
- "Recently, several berries1 have emerged as excellent sources of phytonutrients with putative protective effects toward age-related chronic diseases . Promising evidence in human, animal and cellular studies specifically links berry consumption to lower risk of cardiovascular disease, diabetes and associated complications, cancer, and neurodegenerative diseases [2–5]. In addition to providing a valuable source of vitamins, minerals, and dietary fiber, berries contain a diversity of secondary metabolites, most notably phenolics, which show complex biological activity . "
ABSTRACT: Evidence supports the health promoting benefits of berries, particularly with regard to the prevention and management of chronic diseases such cardio- and cerebrovascular disease, diabetes and Alzheimer's disease. Two related pathophysiological features common to many of these conditions are oxidative stress and the accumulation of advanced glycation endproducts (AGEs). Whereas antioxidant properties are well-established in several species of berries and are believed central to their protective mechanisms, few studies have investigated the effects of berries on AGE formation. Here, employing a series of complementary in vitro assays, we evaluated a collection of wild berry extracts for 1) inhibitory effects on fluorescent-AGE and Nε- (carboxymethyl)lysine-albumin adduct formation, 2) radical scavenging activity and 3) total phenolic and anthocyanin content. All samples reduced AGE formation in a concentration-dependent manner that correlated positively with each extract's total phenolic content and, to a lesser degree, total anthocyanin content. Inhibition of AGE formation was similarly related to radical scavenging activities. Adding antiglycation activity to the list of established functional properties ascribed to berries and their phenolic metabolites, our data provide further insight into the active compounds and protective mechanisms through which berry consumption may aid in the prevention and treatment of chronic diseases associated with AGE accumulation and toxicity. As widely available, safe and nutritious foods, berries represent a promising dietary intervention worthy of further investigation.Plant Foods for Human Nutrition 01/2014; 69(1). DOI:10.1007/s11130-014-0403-3 · 1.98 Impact Factor